ARMS2 and age-related macular degeneration: The mean age of participants diagnosed with AMD was 63.1 years (SD = 5.7) for CFI type 1 RV carriers, 62.2 (4.8) for CFI VUS carriers, 62.9 (5.6) and 63.4 (5.0) for CFH p.Y402H heterozygotes and homozygotes, respectively, 63.0 (5.5) and 63.8 (5.0) for ARMS2 p.A69S heterozygotes and homozygotes, respectively, compared with 63.0 (5.5) across the entire population.